Todd Bazemore
2022
In 2022, Todd Bazemore earned a total compensation of $1M as President and Chief Operating Officer at Kala Pharmaceuticals, a 24% decrease compared to previous year.
Compensation breakdown
| Bonus | $257,500 |
|---|---|
| Option Awards | $242,777 |
| Salary | $515,000 |
| Other | $10,540 |
| Total | $1,025,817 |
Bazemore received $515K in salary, accounting for 50% of the total pay in 2022.
Bazemore also received $257.5K in bonus, $242.8K in option awards and $10.5K in other compensation.
Rankings
In 2022, Todd Bazemore's compensation ranked 2,915th out of 5,505 executives tracked by ExecPay. In other words, Bazemore earned more than 47.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,915 out of 5,505 | 47th |
Division Manufacturing | 1,626 out of 2,984 | 46th |
Major group Chemicals And Allied Products | 752 out of 1,339 | 44th |
Industry group Drugs | 701 out of 1,242 | 44th |
Industry Pharmaceutical Preparations | 506 out of 896 | 44th |
Source: SEC filing on March 13, 2023.
Bazemore's colleagues
We found two more compensation records of executives who worked with Todd Bazemore at Kala Pharmaceuticals in 2022.